share_log

藥明康德：海外監管公告

WUXI APPTEC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 18 10:30
Summary by Moomoo AI
药明康德（股份代號：2359）於香港時間2024年3月18日發布海外監管公告，公布了對2023年度會計師事務所履職情況的評估報告。報告中指出，公司聘請了德勤华永會計師事務所及德勤香港為2023年度境內外財務報告及內部控制的審計機構。德勤华永自1993年成立以來，具有豐富的證券服務業務經驗，並獲得財政部和中國證監會批准從事H股企業審計業務。德勤香港則與全球各地德勤分支機構合作，提供全面的審計及財務咨詢服務。在2023年度的審計過程中，兩家會計師事務所均與公司管理層和治理層進行了充分溝通，並根據公司實際情況制定了相應的審計工作方案。經審計，德勤华永和德勤香港認為公司財務報表在所有重大方面均符合相關會計準則，並出具了標準無保留意見的審計報告。药明康德對德勤华永和德勤香港的審計工作給予了正面評價，認為其展現了良好的職業操守和業務素質。
药明康德（股份代號：2359）於香港時間2024年3月18日發布海外監管公告，公布了對2023年度會計師事務所履職情況的評估報告。報告中指出，公司聘請了德勤华永會計師事務所及德勤香港為2023年度境內外財務報告及內部控制的審計機構。德勤华永自1993年成立以來，具有豐富的證券服務業務經驗，並獲得財政部和中國證監會批准從事H股企業審計業務。德勤香港則與全球各地德勤分支機構合作，提供全面的審計及財務咨詢服務。在2023年度的審計過程中，兩家會計師事務所均與公司管理層和治理層進行了充分溝通，並根據公司實際情況制定了相應的審計工作方案。經審計，德勤华永和德勤香港認為公司財務報表在所有重大方面均符合相關會計準則，並出具了標準無保留意見的審計報告。药明康德對德勤华永和德勤香港的審計工作給予了正面評價，認為其展現了良好的職業操守和業務素質。
Ming Kand Pharmaceuticals (stock code: 2359) issued an Overseas Regulatory Notice on 18 March 2024, Hong Kong time, and published an assessment report on the vacancy status of the Accounting Firm for 2023. According to the report, the company has hired Daqin Huayong Accounting Firm and Delkin Hong Kong as audit bodies for internal and external financial reporting and internal control for 2023. Since its establishment in 1993, DQin Huayong has extensive experience in the securities services business and has been approved by the Ministry of Finance and the PRC to engage in the corporate audit business of H-shares. Delkin Hong Kong cooperates with its branches around the world to provide comprehensive audit and financial advisory services. DURING THE 2023 AUDIT PROCESS, BOTH ACCOUNTING FIRMS COMMUNICATED...Show More
Ming Kand Pharmaceuticals (stock code: 2359) issued an Overseas Regulatory Notice on 18 March 2024, Hong Kong time, and published an assessment report on the vacancy status of the Accounting Firm for 2023. According to the report, the company has hired Daqin Huayong Accounting Firm and Delkin Hong Kong as audit bodies for internal and external financial reporting and internal control for 2023. Since its establishment in 1993, DQin Huayong has extensive experience in the securities services business and has been approved by the Ministry of Finance and the PRC to engage in the corporate audit business of H-shares. Delkin Hong Kong cooperates with its branches around the world to provide comprehensive audit and financial advisory services. DURING THE 2023 AUDIT PROCESS, BOTH ACCOUNTING FIRMS COMMUNICATED WELL WITH THE COMPANY'S MANAGEMENT AND GOVERNANCE AND DEVELOPED AN APPROPRIATE AUDIT WORK PLAN BASED ON THE ACTUAL SITUATION OF THE COMPANY. The auditors consider that the company's financial statements comply with the relevant accounting criteria in all significant respects and produce standard unreserved audit reports. Dao Ming Kand gave a positive assessment of the audit work of Daqin Huayong and DQin Hong Kong, stating that it demonstrated good professional conduct and business quality.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more